HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristoforo Comi Selected Research

Tremor (Tremors)

12/2021Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study.
9/2019Holmes tremor caused by a natalizumab-related progressive multifocal leukoencephalopathy: a case report and brief review of the literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristoforo Comi Research Topics

Disease

27Parkinson Disease (Parkinson's Disease)
05/2023 - 08/2010
22Multiple Sclerosis
01/2024 - 04/2003
8Neurodegenerative Diseases (Neurodegenerative Disease)
12/2023 - 01/2011
6Alzheimer Disease (Alzheimer's Disease)
03/2022 - 12/2009
5Dyskinesias (Dyskinesia)
12/2021 - 08/2010
4Inflammation (Inflammations)
01/2024 - 01/2017
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2017 - 04/2008
3Movement Disorders (Movement Disorder)
12/2023 - 01/2020
3Cognitive Dysfunction
09/2022 - 01/2010
3Autoimmune Diseases (Autoimmune Disease)
01/2019 - 01/2012
2Peripheral Nervous System Diseases (PNS Diseases)
08/2023 - 02/2020
2Breast Neoplasms (Breast Cancer)
08/2023 - 02/2020
2Infections
06/2023 - 01/2012
2Dementia (Dementias)
06/2023 - 12/2009
2COVID-19
12/2022 - 08/2022
2Parkinsonian Disorders (Parkinsonism)
03/2022 - 01/2014
2Tremor (Tremors)
12/2021 - 09/2019
2Demyelinating Diseases (Demyelinating Disease)
01/2019 - 04/2003
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2018 - 06/2009
2Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2011 - 12/2009
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2023
1Chronic Progressive Multiple Sclerosis
10/2023
1Relapsing-Remitting Multiple Sclerosis
10/2023
1Neurobehavioral Manifestations
06/2023
1Neuroinflammatory Diseases
06/2023
1Necrosis
05/2023
1Retinal Artery Occlusion
06/2022
1Central Nervous System Vasculitis
06/2022
1Tauopathies
03/2022
1Hypertension (High Blood Pressure)
12/2021
1Nervous System Diseases (Neurological Disorders)
06/2021
1Disease Progression
04/2021
1Orthostatic Hypotension (Postural Hypotension)
03/2021
1REM Sleep Behavior Disorder
01/2021
1Sleep Wake Disorders
01/2020
1Progressive Multifocal Leukoencephalopathy
09/2019
1Disease Susceptibility (Diathesis)
11/2018

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
01/2024 - 12/2009
13OsteopontinIBA
06/2021 - 06/2005
11Levodopa (L Dopa)FDA LinkGeneric
04/2023 - 08/2010
6Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2011
5CytokinesIBA
05/2023 - 06/2005
3Dopamine (Intropin)FDA LinkGeneric
08/2022 - 10/2012
3alpha-SynucleinIBA
08/2021 - 01/2018
3Protein Isoforms (Isoforms)IBA
01/2019 - 01/2014
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2019 - 01/2014
3AntibodiesIBA
01/2017 - 06/2009
3ProgranulinsIBA
01/2014 - 12/2009
2DNA-Binding Proteins (DNA Binding Protein)IBA
11/2023 - 03/2022
2Paclitaxel (Taxol)FDA LinkGeneric
08/2023 - 02/2020
2tau Proteins (tau Protein)IBA
06/2023 - 03/2022
2Protein AggregatesIBA
01/2023 - 01/2019
2Messenger RNA (mRNA)IBA
12/2022 - 10/2021
2VaccinesIBA
01/2022 - 01/2019
2Carbidopa (Lodosyn)FDA LinkGeneric
06/2021 - 01/2020
2Dopamine Receptors (Dopamine Receptor)IBA
04/2021 - 01/2017
2Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2021
2Oligoclonal BandsIBA
04/2019 - 03/2017
2Dopamine Agonists (Dopamine Agonist)IBA
04/2018 - 10/2012
2PerforinIBA
01/2017 - 01/2013
2Neuroprotective AgentsIBA
02/2015 - 01/2011
2Interleukin-10 (Interleukin 10)IBA
09/2014 - 05/2007
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2024
1Fibrinogen (Factor I)FDA Link
12/2023
1ocrelizumabIBA
10/2023
1teriflunomideIBA
10/2023
1Antiviral Agents (Antivirals)IBA
06/2023
1PolyphenolsIBA
06/2023
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
06/2023
1AntioxidantsIBA
06/2023
1VitaminsIBA
06/2023
1Amyloid (Amyloid Fibrils)IBA
06/2023
1InterleukinsIBA
05/2023
1InterferonsIBA
05/2023
12- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
05/2023
1COVID-19 VaccinesIBA
08/2022
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
08/2022
1Fluorescein (Funduscein)FDA LinkGeneric
06/2022
1SteroidsIBA
06/2022
12019-nCoV Vaccine mRNA-1273IBA
01/2022
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2021
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2021
1Vitamin DFDA LinkGeneric
11/2021
1Amyloid beta-PeptidesIBA
11/2021
1hydroxide ionIBA
03/2021
1Antiparkinson Agents (Antiparkinsonian Agents)IBA
01/2021
1Docetaxel (Taxotere)FDA Link
02/2020
1Taxoids (Taxanes)IBA
02/2020
1taxaneIBA
02/2020
1Albuterol (Salbutamol)FDA LinkGeneric
01/2020
1Natalizumab (Tysabri)FDA Link
09/2019
1Immunoglobulin G (IgG)IBA
04/2019
1Protein SIBA
01/2019
1LigandsIBA
01/2019
1TransferasesIBA
04/2018
1Monoamine Oxidase (MAO)IBA
04/2018

Therapy/Procedure

6Therapeutics
01/2020 - 01/2012
3Drug Therapy (Chemotherapy)
08/2023 - 02/2020
1Mediterranean Diet
06/2023
1Activities of Daily Living (ADL)
01/2020